Xvivo Perfusion AB (publ) (STO: XVIVO)

Xvivo Perfusion AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	449.98	546.09	246.55	398.7	354.24	159.95
Cash & Short-Term Investments	449.98	546.09	246.55	398.7	354.24	159.95
Cash Growth	-24.28%	121.50%	-38.16%	12.55%	121.47%	-14.50%
Accounts Receivable	187.96	98.13	94.5	52.04	40.18	43.73
Other Receivables	-	20.25	9.76	11.88	3.52	5.39
Receivables	187.96	118.37	104.26	63.91	43.7	49.11
Inventory	190.12	141.6	106.57	77.59	59.35	43.87
Prepaid Expenses	-	20.34	10.14	7.34	5.94	6.96
Total Current Assets	828.06	826.41	467.51	547.53	463.23	259.89
Property, Plant & Equipment	121.71	97.55	47.58	26.3	21.33	23.55
Long-Term Investments	-	0.58	0.41	1.16	0.75	0.22
Goodwill	597.64	591.39	625.32	460.23	223.94	65.77
Other Intangible Assets	26.46	30.46	8.49	8.66	6.75	6.22
Long-Term Deferred Tax Assets	-	50.71	39.27	42.17	40.33	12.32
Long-Term Deferred Charges	661.51	598.51	544.51	456.55	393.97	266.52
Other Long-Term Assets	42.81	-	-	-	-	-
Total Assets	2,278	2,196	1,733	1,543	1,150	634.49
Accounts Payable	-	36.05	38.47	21.45	14.47	14.41
Accrued Expenses	-	68.94	52.65	46.96	48.9	31.25
Current Portion of Leases	9.84	10.27	5.55	4.2	3.93	3.4
Current Income Taxes Payable	-	11.87	1.28	0.3	-	-
Current Unearned Revenue	-	3.69	3.17	3.01	3.72	1.78
Other Current Liabilities	140.94	3.66	33.77	28.6	1.24	1.77
Total Current Liabilities	150.78	134.49	134.9	104.52	72.25	52.6
Long-Term Leases	14.74	21.17	4.46	1.52	3.29	2.15
Long-Term Deferred Tax Liabilities	-	29.29	25.77	25.08	24.85	0.9
Other Long-Term Liabilities	29.5	65.62	137.83	126.02	41.46	1.31
Total Liabilities	195.02	250.57	302.95	257.15	141.85	56.97
Common Stock	0.81	0.81	0.76	0.75	0.73	0.68
Additional Paid-In Capital	1,769	1,764	1,314	1,253	1,007	515.75
Retained Earnings	255.37	119.57	27.75	9.28	1.13	44.86
Comprehensive Income & Other	57.55	60.89	87.78	22.09	-0.18	16.23
Shareholders' Equity	2,083	1,945	1,430	1,285	1,008	577.52
Total Liabilities & Equity	2,278	2,196	1,733	1,543	1,150	634.49
Total Debt	24.58	31.44	10.01	5.72	7.21	5.55
Net Cash (Debt)	425.41	514.65	236.54	392.98	347.02	154.4
Net Cash Growth	-25.20%	117.57%	-39.81%	13.24%	124.76%	-17.46%
Net Cash Per Share	13.63	17.19	8.01	13.58	12.77	5.76
Filing Date Shares Outstanding	31.5	31.5	29.83	29.5	28.72	26.6
Total Common Shares Outstanding	31.5	31.5	29.83	29.5	28.72	26.6
Working Capital	677.28	691.92	332.61	443.01	390.98	207.29
Book Value Per Share	66.13	61.75	47.94	43.58	35.11	21.71
Tangible Book Value	1,459	1,323	796.33	816.56	777.77	505.53
Tangible Book Value Per Share	46.32	42.01	26.69	27.68	27.08	19.00
Machinery	-	153.61	98.52	68.04	58.77	49.75

Source: S&P Capital IQ. Standard template. Financial Sources.